Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma

被引:63
|
作者
Young, Jonathan R. [1 ]
Coy, Heidi [1 ]
Kim, Hyun J. [1 ]
Douek, Michael [1 ]
Lo, Pechin [1 ]
Pantuck, Allan J. [2 ]
Raman, Steven S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, 757 Westwood Plaza,Ste 1638, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
关键词
MRI; multiphasic; oncocytoma; renal cell carcinoma; PATHOLOGICAL FINDINGS; HISTOLOGIC SUBTYPES; HELICAL CT; TUMORS; CLASSIFICATION; NEOPLASMS; PARAMETERS; FEATURES; DISEASE; SYSTEM;
D O I
10.2214/AJR.16.17152
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the performance of relative enhancement on multiphasic MRI to differentiate clear cell renal cell carcinoma (RCC) from other RCC subtypes (papillary and chromophobe) and oncocytoma. MATERIALS AND METHODS. For this study, we derived a cohort of 34 clear cell RCCs, nine oncocytomas, 12 papillary RCCs, and 10 chromophobe RCCs with a preoperative multiphasic dynamic contrast-enhanced MRI study with up to four phases (i.e., unenhanced, corticomedullary, nephrographic, excretory) from 2005 to 2016. These groups were evaluated for multiphasic enhancement and were compared using Kruskal-Wallis and Mann-Whitney tests. ROC curves were constructed and logistic regression analyses were performed to evaluate the performance of multiphasic enhancement in differentiating clear cell RCCs from the other three groups. RESULTS. Clear cell RCCs exhibited significantly greater relative signal intensity compared with uninvolved renal cortex in the corticomedullary phase (mean, 2.9) than oncocytomas (-21.7, p = 0.001), papillary RCCs (-53.0, p < 0.001), and chromophobe RCCs (-21.0, p < 0.001). Relative signal intensity in the corticomedullary phase differentiated clear cell RCCs from oncocytomas with an AUC of 0.90 and with an accuracy of 84% (32/38), sensitivity of 90% (27/30), and specificity of 63% (5/8) after controlling for lesion size, patient age, and patient sex. Relative corticomedullary signal intensity differentiated clear cell RCCs from oncocytomas and other RCC subtypes with an AUC of 0.93 and with an accuracy of 90% (53/59), sensitivity of 90% (27/30), and specificity of 90% (26/29) after controlling for lesion size, patient age, and patient sex. CONCLUSION. Multiphasic MRI enhancement may assist in differentiating clear cell RCC from oncocytomas and other RCC subtypes, if validated in prospective studies.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 50 条
  • [1] Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT
    Young, Jonathan R.
    Margolis, Daniel
    Sauk, Steven
    Pantuck, Allan J.
    Sayre, James
    Raman, Steven S.
    RADIOLOGY, 2013, 267 (02) : 444 - 453
  • [2] Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT
    Young, Jonathan R.
    Coy, Heidi
    Douek, Michael
    Lo, Pechin
    Sayre, James
    Pantuck, Allan J.
    Raman, Steven S.
    ABDOMINAL RADIOLOGY, 2017, 42 (07) : 1911 - 1918
  • [3] Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT
    Young, Jonathan R.
    Young, Jocelyn A.
    Margolis, Daniel J. A.
    Sauk, Steven
    Sayre, James
    Pantuck, Allan J.
    Raman, Steven S.
    ACADEMIC RADIOLOGY, 2017, 24 (10) : 1226 - 1232
  • [4] Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters
    Moldovanu, Claudia-Gabriela
    Petresc, Bianca
    Lebovici, Andrei
    Tamas-Szora, Attila
    Suciu, Mihai
    Crisan, Nicolae
    Medan, Paul
    Buruian, Mircea Marian
    MEDICINA-LITHUANIA, 2020, 56 (11): : 1 - 12
  • [5] Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem?
    Ng, Keng Lim
    Rajandram, Retnagowri
    Morais, Christudas
    Yap, Ning Yi
    Samaratunga, Hema
    Gobe, Glenda C.
    Wood, Simon T.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (02) : 97 - 104
  • [6] Differentiation of Papillary Renal Cell Carcinoma Subtypes on CT and MRI
    Egbert, Nathan D.
    Caoili, Elaine M.
    Cohan, Richard H.
    Davenport, Matthew S.
    Francis, Isaac R.
    Kunju, L. Priya
    Ellis, James H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 201 (02) : 347 - 355
  • [7] Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT
    Jonathan R. Young
    Heidi Coy
    Michael Douek
    Pechin Lo
    James Sayre
    Allan J. Pantuck
    Steven S. Raman
    Abdominal Radiology, 2017, 42 : 1911 - 1918
  • [8] Differentiation of Renal Oncocytoma and Renal Clear Cell Carcinoma Using Relative CT Enhancement Ratio
    Ren, An
    Cai, Feng
    Shang, Yan-Ning
    Ma, En-Sen
    Huang, Zhen-Guo
    Wang, Wu
    Lu, Yan
    Zhang, Xue-Zhe
    CHINESE MEDICAL JOURNAL, 2015, 128 (02) : 175 - 179
  • [9] Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI
    Akin, Isil Basara
    Altay, Canan
    Guler, Ezgi
    Camlidag, Ilkay
    Harman, Mustafa
    Danaci, Murat
    Tuna, Burcin
    Yorukoglu, Kutsal
    Secil, Mustafa
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2019, 25 (01) : 5 - 13
  • [10] MRI Features of Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
    Rosenkrantz, Andrew B.
    Hindman, Nicole
    Fitzgerald, Erin F.
    Niver, Benjamin E.
    Melamed, Jonathan
    Babb, James S.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (06) : W421 - W427